Veracyte (VCYT) Stock Statistics & Valuation Metrics

Veracyte has a market cap or net worth of $3.32B. The enterprise value is $4.37K.

Veracyte has 80,390,730 shares outstanding. The number of shares has decreased by -2.65% in one year.

Veracyte’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 5.34%.

The current PE Ratio of Veracyte is 28.6. Veracyte’s PEG ratio is 0.31.

In the last 12 months, Veracyte had revenue of 517.14M and earned 66.35M in profits. Earnings per share was 0.84.

In the last 12 months, operating cash flow was 178.38M and capital expenditures -12.93M, giving a free cash flow of 165.46M billion.

Veracyte pays an annual dividend of ―, resulting in a dividend yield of ―

Veracyte upcoming earnings date is Nov 10, 2026, After Close (Confirmed).

Veracyte as a current ratio of 8.15, with Debt / Equity ratio of 2.89%

In the past 12 months, Veracyte has paid 1.85M in taxes.

Veracyte EV to EBITDA ratio is 33.31, with an EV/FCF ratio of 23.58.

Veracyte has $485.23M in cash and marketable securities with $40.11M in debt, giving a net cash position of $445.13M billion.

Gross margin is 72.09%, with operating margin of 14.34%, and net profit margin of 12.83%.

The average price target for Veracyte is $57.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy